Sotradecol Related Published Studies
Well-designed clinical trials related to Sotradecol (Sodium Tetradecyl Sulfate)
Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). [2010.06]
Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). [2010]
Comparison of ethanol and sodium tetradecyl sulfate in the sclerotherapy of renal cyst. [2007.08]
Well-designed clinical trials possibly related to Sotradecol (Sodium Tetradecyl Sulfate)
Comparison of aspiration-sclerotherapy with hydrocelectomy in the management of hydrocele: a prospective randomized study. [2009.08]
Reverse foam sclerotherapy of the great saphenous vein with sapheno-femoral ligation compared to standard and invagination stripping: a prospective clinical series. [2008.10]
Other research related to Sotradecol (Sodium Tetradecyl Sulfate)
Comparison of sonographically guided percutaneous sodium tetradecyl sulfate
injection with ethanol injection in the treatment of benign nonfunctioning
thyroid nodules. [2014]
Deactivation of sodium tetradecyl sulphate injection by blood proteins. [2011.04]
Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. [2011.03]
Sodium tetradecyl sulphate direct intralesional sclerotherapy of venous malformations of the vulva and vagina: report of five cases. [2011.02]
Extensive muscle necrosis and infection following treatment of a lower extremity vascular malformation with Sotradecol and absolute ethanol. [2010.07]
The first case of takotsubo cardiomyopathy associated with sodium tetradecyl sulphate sclerotherapy. [2010.04]
Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations. [2010.03]
The impact of different concentrations of sodium tetradecyl sulphate and initial balloon denudation on endothelial cell loss and tunica media injury in a model of foam sclerotherapy. [2010.03]
Histological and biomechanical effects of palatal sclerotherapy in the horse using sodium tetradecyl sulfate. [2010.03]
Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma. [2008.09]
Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate. [2008.07]
Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. [2008.07]
Initial experience with 3% sodium tetradecyl sulfate foam and fibered coils for management of adolescent varicocele. [2008.02]
Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate--outcome in 244 patients. [2008.02]
Anaphylactoid reaction after the use of sodium tetradecyl sulfate: a case report. [2007.10]
FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy. [2007.09]
Use of intraoperative sodium tetradecyl sulfate for the treatment of a spinal epidural hemangioma. Technical note. [2007.08]
Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. [2007.03]
Other possibly related research studies
Percutaneous treatment of lymphatic malformations. [2009.08]
Aesthetic treatment of leg veins. [2008.09]
Efficacy of graduated compression stockings for an additional 3 weeks after sclerotherapy treatment of reticular and telangiectatic leg veins. [2009.01]
Primary venous aneurysms of the superficial venous system. [2008.10]
Palatal sclerotherapy: a potentially useful treatment of intermittent dorsal displacement of the soft palate in juvenile standardbred racehorses. [2008.06]
Single dose injection snoreplasty: investigation or treatment? [2008.11]
The effect of endovenous laser ablation on restless legs syndrome. [2008]
Retrograde percutaneous sclerotherapy of left idiopathic varicocele in children: results and follow-up. [2008.05]
Vallecular varix causing diagnostic confusion in hematemesis. [2008.12]
Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. [2008.01]
Immediate pathologic effects on the vein wall of foam sclerotherapy. [2007.10]
Endoscopic abnormalities in the oesophagus after variceal sclerotherapy--a long-term follow up study. [2007.01]
Feasibility study of inhaled hepatitis B vaccine formulated with tetradecylmaltoside. [2008.03]
Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope. [2007.08]
Efficacy of local sclerosing agents on hemostasis of hepatic bleeding. [2007.06]
Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation. [2007.07]
The use of foam sclerotherapy for varicose veins: a survey of the members of the Vascular Society of Great Britain and Ireland. [2007.08]
Management of oral lesions in HIV-positive patients. [2007.03]
Profuse bleeding in patients with chronic venous insufficiency. [2007.03]
[Injection sclerotherapy for varicosities of the lower limb: 25 years of experience with 115000 injections] [2007.01.14]
Cyanoacrylate glue in the management of gastric varices. [2009.02]
Sclerosants: a comparative review. [2010.06]
Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia. [2009.04]
Complications and side-effects of foam sclerotherapy. [2009.12]
Intravascular papillary endothelial hyperplasia of the lower lip: surgical approach and review of the literature. [2009.12]
Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy. [2009]
Technique and early results of ultrasound-guided foam sclerotherapy of the long saphenous vein for treatment of varicose veins. [2009.03]
Mechanochemical tumescentless endovenous ablation: final results of the initial clinical trial. [2011.07.29]
Air versus physiological gas for ultrasound guided foam sclerotherapy treatment of varicose veins. [2011.07]
Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic recurrent great saphenous varicose veins. [2011.07]
Treatment of a branchial sinus tract by sclerotherapy. [2011.02]
An investigation into the influence of various gases and concentrations of sclerosants on foam stability. [2011.01]
New technique to heal venous ulcers: terminal interruption of the reflux source (TIRS). [2010.09]
Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. [2011.06]
Duplex ultrasound outcomes following ultrasound-guided foam sclerotherapy of symptomatic primary great saphenous varicose veins. [2010.10]
Experience with concomitant ultrasound-guided foam sclerotherapy and endovenous laser treatment in chronic venous disorder and its influence on Health Related Quality of Life: interim analysis of more than 1000 consecutive procedures. [2009.08]
An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study. [2011.09.16]
Sclerotherapy for lower limb telangiectasias. [2011]
An investigation of side-effects and efficacy of foam-based sclerotherapy with
carbon dioxide or room air in the treatment of reticular leg veins: a pilot
study. [2012]
Interim results on abolishing reflux alongside a randomized clinical trial on
laser ablation with phlebectomies versus foam sclerotherapy. [2013]
|